Comment on Kenvue IPO: Stock priced as Johnson & Johnson spinoff set to trade today on NYSE

Kenvue IPO: Stock priced as Johnson & Johnson spinoff set to trade today on NYSE

The newly public consumer health company will control some of JNJ’s most well known brands, including Neutrogena, Listerine, and Tylenol. Kenvue, a subsidiary of Johnson & Johnson, is holding its initial public offering and expected to begin trading on the public markets today. If you haven’t heard of Kenvue before, that’s okay.

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News